Enovis Corporation has grown revenue 12% a year over three years and −4.4% a year over five. Revenue growth, 3-year annual rate: +12% (Medical Devices median +12%). Revenue growth, 5-year rate: −4.4%, growth has picked up over the last three years. Years of annual history on file: 17, FY2009 to FY2025, as filed.

ENOVEnovis Corporation

Healthcare

$17.71-45% 1Y

$17.71

$17.4452 weeks$32.87

Is it growing?

Mixed

Neither accelerating nor breaking down: nothing decisive, though operating margin narrowing (−12.2 points).

1 to watch, 1 neutral, 1 without data

Revenue trend+5% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: −4% a year.

Margin direction−12.2 points operating

Trailing-twelve-month operating margin, -46.2% now against -34.0% a year earlier.

All from SEC EDGAR, as of Jul 3, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbetter than 73% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is ENOV growing?

Enovis Corporation has grown revenue 12% a year over three years and −4.4% a year over five.

+12%

Revenue growth, 3-year annual rate · Medical Devices median +12% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −4.4%
Revenue growth, 5-year rate · +12% over three · growth has picked up over the last three years
Years of annual history on file: 17
Years of annual history on file · FY2009 to FY2025, as filed

Details›